| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.13B | 72.24B | 70.75B | 73.14B | 64.31B | 55.17B |
| Gross Profit | 16.94B | 17.94B | 17.32B | 15.86B | 13.30B | 11.41B |
| EBITDA | 7.85B | 9.67B | 8.79B | 8.32B | 6.14B | 5.02B |
| Net Income | 4.87B | 5.64B | 5.65B | 5.10B | 3.63B | 2.75B |
Balance Sheet | ||||||
| Total Assets | 100.54B | 104.54B | 103.10B | 100.54B | 89.74B | 80.77B |
| Cash, Cash Equivalents and Short-Term Investments | 25.45B | 22.13B | 24.50B | 24.04B | 22.33B | 23.36B |
| Total Debt | 4.35B | 3.16B | 4.49B | 4.14B | 3.67B | 1.35B |
| Total Liabilities | 21.07B | 19.21B | 22.44B | 24.70B | 21.08B | 17.01B |
| Stockholders Equity | 76.26B | 81.83B | 77.28B | 72.82B | 65.89B | 61.41B |
Cash Flow | ||||||
| Free Cash Flow | 1.71B | 3.52B | 1.53B | 2.52B | -2.03B | 1.90B |
| Operating Cash Flow | 5.15B | 4.47B | 7.32B | 4.18B | 2.03B | 2.69B |
| Investing Cash Flow | -3.13B | -2.38B | -5.55B | -1.83B | -4.12B | -819.00M |
| Financing Cash Flow | -1.85B | -4.32B | -1.79B | -819.00M | 937.00M | -1.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥64.59B | 11.67 | ― | 3.95% | 2.75% | 25.75% | |
80 Outperform | ¥72.42B | 12.40 | ― | 2.63% | 2.11% | 0.91% | |
78 Outperform | ¥90.51B | 23.69 | 7.34% | 3.69% | -0.50% | -6.61% | |
74 Outperform | ¥34.34B | 11.68 | ― | 2.78% | 0.66% | -4.90% | |
66 Neutral | ¥29.70B | 14.14 | ― | 2.13% | 0.12% | 59.33% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥73.54B | 21.55 | ― | 0.55% | 2.93% | 10.00% |